Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone and naloxone ratio-finding study in opioid-induced constipation with pain
NL-OMON37097Phase 3Active, not recruiting
- Sponsor
- Mundipharma
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydromorphone, naloxone in pain, sponsored by Mundipharma. Started Mar 2010; status: active, not recruiting.
02
Drugs
hydromorphonenaloxone
03
Conditions
pain
Beyond the preview
Go deeper on NL-OMON37097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37097.